Evidence map›Paper›PMID 26956944›Full record

ArticleMalaria journal2016

Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania.

Idda Romore, Ritha J A Njau, Innocent Semali, Aziza Mwisongo, Antoinette Ba Nguz, Hassan Mshinda, Marcel Tanner, Salim Abdulla

Abstract read
In one paragraph

Article in Malaria journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Idda RomoreSwiss Tropical and Public Health Institute, Socinstrasse 57, Postfach, 4002, Basel, Switzerland. iromore@ihi.or.tz.
Ritha J A NjauWorld Health Organization Country Office, P.O Box 9292, Dar Es Salaam, Tanzania. Njau-njaur@who.int.
Innocent SemaliMuhimbili University of Health and Allied Science (MUHAS), P.O. Box 65015, Dar Es Salaam, Tanzania. innosemali@yahoo.com.
Aziza MwisongoCentres for Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Mwisongo2@wits.ac.tz.
Antoinette Ba NguzAgence de Médecine Préventive, 08BP 660, Abidjan, Côte d'Ivoire. aba-nguz@aamp.org.
Hassan MshindaCommission for Science and Technology (COSTECH), P.O. Box 4302, Dar Es Salaam, Tanzania. hmshinda@costec.or.tz.
Marcel TannerSwiss Tropical and Public Health Institute, Socinstrasse 57, Postfach, 4002, Basel, Switzerland. marcel.tanner@unibas.ch.
Salim AbdullaIfakara Health Institute (IHI), P.O. Box 78373, Dar Es Salaam, Tanzania. sabdulla@ihi.or.tz.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundTraditionally, it has taken decades to introduce new interventions in low-income countries. Several factors account for these delays, one of which is the absence of a framework to facilitate comprehensive understanding of policy process to inform policy makers and stimulate the decision-making process. In the case of the proposed introduction of malaria vaccines in Tanzania, a specific framework for decision-making will speed up the administrative process and shorten the time until the vaccine is made available to the target population.

methodsQualitative research was used as a basis for developing the Policy Framework. Interviews were conducted with government officials, bilateral and multilateral partners and other stakeholders in Tanzania to assess malaria treatment policy changes and to draw lessons for malaria vaccine adoption.

resultsThe decision-making process for adopting malaria interventions and new vaccines in general takes years, involving several processes: meetings and presentations of scientific data from different studies with consistent results, packaging and disseminating evidence and getting approval for use by the Ministry of Health and Social Welfare (MOHSW). It is influenced by contextual factors; Promoting factors include; epidemiological and intervention characteristics, country experiences of malaria treatment policy change, presentation and dissemination of evidence, coordination and harmonization of the process, use of international scientific evidence. Barriers factors includes; financial sustainability, competing health and other priorities, political will and bureaucratic procedures, costs related to the adoption and implementations of interventions, supply and distribution and professional compliance with anti-malarial drugs.

conclusionThe framework facilitates the synthesis of information in a coherent way, enabling a clearer understanding of the policy process, thereby speeding up the policy decision-making process and shortening the time for a malaria vaccine to become available.

Indexed as

Malaria VaccinesDecision Support TechniquesHealth PolicyHumansMalariaQualitative ResearchTanzaniaMalaria Vaccines

Identifiers

PMID26956944
PMCPMC4782348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.